PLI schemes should focus on firms making pharma products: Bharat Biotech
Production-linked incentive schemes should also focus on companies providing packaging materials and other services in addition to manufacturers of branded pharmaceutical items to reduce import dependence, according to Bharat Biotech Executive Director Sai Prasad.
He also emphasised on shifting the focus towards innovative pharmaceuticals products in order to enhance the margins for industry players.
"We already have policies like production-linked incentive (PLI) schemes and research-based schemes and these policies are going to be very helpful for the sector... It is our view that such policies should also focus on companies which provide goods and services to the pharma industry," Prasad told PTI in an interaction.
The incentives also need to be given to single-use consumer companies, raw material packaging firms and other service providers in the pharmaceutical supply chain, he added.
"If the ecosystem is strong only then the branded companies could be strong," Prasad said.
He